Kihyun Kim, Ph.D. - Publications

2007 Social Work: Doctor of Philosophy University of Southern California, Los Angeles, CA, United States 
Social Work, Individual and Family Studies

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Kim K, Mennen FE, Trickett PK. Patterns and correlates of co-occurrence among multiple types of child maltreatment. Child & Family Social Work. 22: 492-502. PMID 29225485 DOI: 10.1111/cfs.12268  0.92
2016 Yi J, Kim MA, Kim K, Hong JS. Exploring Social Service Providers' Perspectives on Barriers to Social Services for Early Adjustment of Immigrant Adolescents in South Korea. Journal of Immigrant and Minority Health / Center For Minority Public Health. PMID 27013328 DOI: 10.1007/s10903-016-0406-2  0.68
2015 Lim SH, Park S, Jang JH, Kim K, Kim HJ, Kim SH, Kang CI, Chung DR, Peck KR, Lee J, Cha HS, Koh EM, Ko YH, Kim WS, Jung CW, et al. Clinical significance of bone marrow hemophagocytosis in adult patients with malignancy and non-malignancy-induced hemophagocytic lymphohistiocytosis. Annals of Hematology. PMID 26453074 DOI: 10.1007/s00277-015-2523-8  0.68
2015 Park S, Kim K, Jang JH, Kim SJ, Kim WS, Kang ES, Jung CW. KIR alloreactivity based on the receptor-ligand model is associated with improved clinical outcomes of allogeneic hematopoietic stem cell transplantation: Result of single center prospective study. Human Immunology. PMID 26407827 DOI: 10.1016/j.humimm.2015.09.009  0.68
2015 Lim AY, Lee JH, Jung KS, Gwag HB, Kim do H, Kim SJ, Lee GY, Kim JS, Kim HJ, Lee SY, Lee JE, Jeon ES, Kim K. Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience. The Korean Journal of Internal Medicine. 30: 496-505. PMID 26161016 DOI: 10.3904/kjim.2015.30.4.496  0.68
2015 Kim DY, Joo YD, Lim SN, Kim SD, Lee JH, Lee JH, Kim DH, Kim K, Jung CW, Kim I, Yoon SS, Park S, Ahn JS, Yang DH, Lee JJ, ... ... Kim KH, et al. Nilotinib combined with multi-agent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia. Blood. PMID 26065651 DOI: 10.1182/blood-2015-03-636548  0.68
2015 Lee JY, Lim SH, Lee MY, Kim H, Sinn DH, Gwak GY, Choi MS, Lee JH, Jung CW, Jang JH, Kim WS, Kim SJ, Kim K. Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 25832927 DOI: 10.1111/liv.12838  0.68
2015 Kim HJ, Yoon SS, Eom HS, Kim K, Kim JS, Lee JJ, Bang SM, Min CK, Park JS, Lee JH. Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea. Blood Research. 50: 7-18. PMID 25830125 DOI: 10.5045/br.2015.50.1.7  0.68
2015 Shin HJ, Kim K, Lee JJ, Song MK, Lee EY, Park SH, Kim SH, Jang MA, Kim SJ, Chung JS. The t(11;14)(q13;q32) translocation as a poor prognostic parameter for autologous stem cell transplantation in myeloma patients with extramedullary plasmacytoma. Clinical Lymphoma, Myeloma & Leukemia. 15: 227-35. PMID 25812994 DOI: 10.1016/j.clml.2014.12.007  0.68
2015 Jang MA, Lee GY, Kim K, Kim SJ, Kim JS, Lee SY, Kim HJ, Jeon ES. Asp58Ala is the predominant mutation of the TTR gene in Korean patients with hereditary transthyretin-related amyloidosis. Annals of Human Genetics. 79: 99-107. PMID 25644864 DOI: 10.1111/ahg.12101  0.68
2014 Lee JY, Lim SH, Kim SJ, Lee GY, Lee JE, Choi JO, Kim JS, Kim HJ, Lee SY, Min JH, Jeon ES, Kim K. Bortezomib, melphalan, and prednisolone combination chemotherapy for newly diagnosed light chain (AL) amyloidosis. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 21: 261-6. PMID 25248716 DOI: 10.3109/13506129.2014.960560  0.68
2014 Lee HS, Kim K, Yoon DH, Kim JS, Bang SM, Lee JO, Eom HS, Lee H, Kim I, Lee WS, Bae SH, Kim SH, Lee MH, Do YR, Lee JH, et al. Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in Korea. Biomed Research International. 2014: 253243. PMID 24995279 DOI: 10.1155/2014/253243  0.68
2014 Ahn SY, Jung SH, Joo YD, Lee WS, Lee SM, Choi CW, Kim SJ, Kim K, Lee JJ. Early response-based intensification of primary therapy in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplantation: phase II study. Annals of Hematology. 93: 1571-7. PMID 24728664 DOI: 10.1007/s00277-014-2067-3  0.68
2014 Lee GY, Kim K, Choi JO, Kim SJ, Kim JS, Choe YH, Grogan MA, Jeon ES. Cardiac amyloidosis without increased left ventricular wall thickness. Mayo Clinic Proceedings. 89: 781-9. PMID 24702732 DOI: 10.1016/j.mayocp.2014.01.013  0.68
2014 Oh S, Koo DH, Kwon MJ, Kim K, Suh C, Min CK, Yoon SS, Shin HJ, Jo DY, Kwak JY, Kim JS, Sohn SK, Joo YD, Eom HS, Kim SH, et al. Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study. Annals of Hematology. 93: 1353-61. PMID 24671365 DOI: 10.1007/s00277-014-2057-5  0.68
2014 Kim K, Kim SJ, Voelter V, Suh C, Yoon SS, Lee JJ, Kwak JY, Ryoo HM, Kim YS, Moon JH, Park SK, Kim SH, Mun YC, Kim JS, Eom HS, ... ... Kim KH, et al. Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patients. Annals of Hematology. 93: 113-21. PMID 24026427 DOI: 10.1007/s00277-013-1893-z  0.68
2013 Kim SJ, Lee GY, Jang HR, Choi JO, Kim JS, Kim HJ, Lee SY, Min JH, Jeon ES, Kim K. Autologous stem cell transplantation in light-chain amyloidosis patients: a single-center experience in Korea. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 20: 204-11. PMID 23914780 DOI: 10.3109/13506129.2013.824417  0.68
2013 Jang MA, Yoo EH, Kim K, Kim WS, Jung CW, Kim SH, Kim HJ. Chronic lymphocytic leukemia in Korean patients: frequent atypical immunophenotype and relatively aggressive clinical behavior. International Journal of Hematology. 97: 403-8. PMID 23400412 DOI: 10.1007/s12185-013-1286-z  0.68
2013 Park S, Lee SJ, Kim K, Jang JH, Kim DH, Lee KH, Lee JH, Lee JH, Kim DY, Jang DY, Kim H, Park JH, Ryoo HM, Bae SH, Kim MK, et al. Inclusion of hemoglobin level in prognostic score provides better prognostic stratification in patients with acute promyelocytic leukemia (APL). International Journal of Hematology. 97: 388-96. PMID 23397209 DOI: 10.1007/s12185-013-1276-1  0.68
2013 Lee HS, Kim YS, Kim K, Kim JS, Kim HJ, Min CK, Suh C, Eom HS, Yoon SS, Lee JH, Kim MK, Kim SH, Bae SH, Mun YC, Jo DY, et al. Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation. Journal of Korean Medical Science. 28: 80-6. PMID 23341716 DOI: 10.3346/jkms.2013.28.1.80  0.68
2013 Jun HJ, Kim K, Kim SJ, Mun YC, Bang SM, Won JH, Kim CS, Lee JH. Clinical features and treatment outcome of primary systemic light-chain amyloidosis in Korea: results of multicenter analysis. American Journal of Hematology. 88: 52-5. PMID 23027340 DOI: 10.1002/ajh.23333  0.68
2012 Ahn HK, Jang JH, Kim K, Kim HJ, Kim SH, Jung CW, Kim DH. Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity. American Journal of Hematology. 87: 37-41. PMID 22120708 DOI: 10.1002/ajh.22193  0.68
2012 Kim HJ, Yoon SS, Lee DS, Sohn SK, Eom HS, Lee JL, Chung JS, Kim K, Suh C, Won JH, Kim JS, Park JS, Kang HJ, Seong CM, Kim CS, et al. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial. Annals of Hematology. 91: 249-56. PMID 21789621 DOI: 10.1007/s00277-011-1298-9  0.68
2011 Trickett PK, Kim K, Prindle J. Variations in emotional abuse experiences among multiply maltreated young adolescents and relations with developmental outcomes. Child Abuse & Neglect. 35: 876-86. PMID 22018516 DOI: 10.1016/j.chiabu.2011.08.001  0.68
2011 Kim K, Trickett PK, Putnam FW. Attachment representations and anxiety: Differential relationships among mothers of sexually abused and comparison girls Journal of Interpersonal Violence. 26: 498-521. PMID 20442447 DOI: 10.1177/0886260510363416  0.68
2010 Iastrebner M, Jang JH, Nucifora E, Kim K, Sackmann F, Kim DH, Orlando S, Jung CW, Basquiera A, Klein G, Santini F, Bernard HI, Korin J, Taborda G. Decitabine in myelodysplastic syndromes and chronic myelomonocytic leukemia: Argentinian/South Korean multi-institutional clinical experience. Leukemia & Lymphoma. 51: 2250-7. PMID 20929328 DOI: 10.3109/10428194.2010.524324  0.68
2010 Mennen FE, Kim K, Sang J, Trickett PK. Child neglect: definition and identification of youth's experiences in official reports of maltreatment. Child Abuse & Neglect. 34: 647-58. PMID 20643482 DOI: 10.1016/j.chiabu.2010.02.007  0.68
2010 Kim K, Trickett PK, Putnam FW. Childhood experiences of sexual abuse and later parenting practices among non-offending mothers of sexually abused and comparison girls Child Abuse and Neglect. 34: 610-622. PMID 20541259 DOI: 10.1016/j.chiabu.2010.01.007  0.68
2010 Kim ST, Lee MH, Kim SY, Kim SJ, Kim DH, Jang JH, Kim K, Kim WS, Jung CW. A randomized trial of preemptive therapy for prevention of cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 91: 886-91. PMID 20454943 DOI: 10.1007/s12185-010-0580-2  0.68
2010 Lee SS, Suh C, Kim BS, Chung J, Joo YD, Ryoo HM, Do YR, Jin JY, Kang HJ, Lee GW, Lee MH, Shim H, Kim K, Yoon SS, Bang SM, et al. Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety. Annals of Hematology. 89: 905-12. PMID 20349060 DOI: 10.1007/s00277-010-0943-z  0.68
2010 Kim K, Kong SY, Fulciniti M, Li X, Song W, Nahar S, Burger P, Rumizen MJ, Podar K, Chauhan D, Hideshima T, Munshi NC, Richardson P, Clark A, Ogden J, et al. Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo. British Journal of Haematology. 149: 537-49. PMID 20331454 DOI: 10.1111/j.1365-2141.2010.08127.x  0.68
2010 Yun J, Kim SJ, Kim JA, Kong JH, Lee SH, Kim K, Ko YH, Kim WS. Clinical features and treatment outcomes of non-Hodgkin's lymphomas involving rare extranodal sites: a single-center experience. Acta Haematologica. 123: 48-54. PMID 19955711 DOI: 10.1159/000262291  0.68
2010 Chang MH, Kim KH, Kim HS, Jun HJ, Kim DH, Jang JH, Kim K, Jung CW. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia. European Journal of Haematology. 84: 154-9. PMID 19912311 DOI: 10.1111/j.1600-0609.2009.01378.x  0.68
2009 Kim SJ, Kim K, Kim BS, Jo DY, Kang HJ, Kim JS, Mun YC, Kim CS, Sohn SK, Eom HS, Kwak JY, Shim H, Yoon HJ, Jin JY, Min CK, et al. Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma Registry. Acta Haematologica. 122: 200-10. PMID 19887776 DOI: 10.1159/000253027  0.68
2009 Kim SJ, Kim K, Kim BS, Kim CY, Suh C, Huh J, Lee SW, Kim JS, Cho J, Lee GW, Kang KM, Eom HS, Pyo HR, Ahn YC, Ko YH, et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6027-32. PMID 19884539 DOI: 10.1200/JCO.2009.23.8592  0.68
2009 Park CH, Kimler BF, Yi SY, Park SH, Kim K, Jung CW, Kim SH, Lee ER, Rha M, Kim S, Park MH, Lee SJ, Park HK, Lee MH, Yoon SS, et al. Depletion of L-ascorbic acid alternating with its supplementation in the treatment of patients with acute myeloid leukemia or myelodysplastic syndromes. European Journal of Haematology. 83: 108-18. PMID 19284416 DOI: 10.1111/j.1600-0609.2009.01252.x  0.68
2009 Trickett PK, Mennen FE, Kim K, Sang J. Emotional abuse in a sample of multiply maltreated, urban young adolescents: issues of definition and identification. Child Abuse & Neglect. 33: 27-35. PMID 19178945 DOI: 10.1016/j.chiabu.2008.12.003  0.68
2007 Kim K, Noll JG, Putnam FW, Trickett PK. Psychosocial characteristics of nonoffending mothers of sexually abused girls: Findings from a prospective, multigenerational study Child Maltreatment. 12: 338-351. PMID 17954940 DOI: 10.1177/1077559507305997  0.68
Show low-probability matches.